Next generation sequencing and peripheral blood ctdna testing services (research)
Active Awarded
- Contract number
- 36C24E26N0059
- Awardee
-
Natera Inc. UEI VD6KZ6NCS9K8
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $73,500
Award facts
- Contract value 100% obligated
- $73,500.00 Current and potential, with all options
- Completion date 65% complete
- Current and potential, with all options
- Funding agency
- Veterans Integrated Service Network 10 Veterans Health Administration, Department of Veterans Affairs
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Austin, TX 78753, USA
Award details come from SAM.gov/FPDS.
About this award
Natera Inc. has been awarded a delivery order valued at $73.5K by the Veterans Integrated Service Network 10 (VISN 10), a civilian component of the Department of Veterans Affairs, for next-generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services to support VA research initiatives. The contract, awarded on March 3, 2026, with an ultimate completion date of March 2, 2027, operates under a firm fixed-price structure with no set-aside designation, reflecting competitive award based on Natera's specialized technological capabilities in advanced genetic and molecular diagnostic testing. Performance will be conducted in Austin, Texas, where Natera maintains its headquarters.
This delivery order supports the VA's precision oncology research programs by leveraging Natera's proprietary diagnostic assays to analyze patient blood samples for circulating tumor DNA detection and genomic profiling. The award is consistent with Natera's established relationship with the VA, which has previously engaged the company through two significant Indefinite Delivery Contracts—one valued at $147.08K for next-generation sequencing and ctDNA testing services, and another valued at $6.72M for minimal residual disease testing. These services enable VA medical centers across multiple networks to provide advanced cell-free DNA testing that supports cancer treatment decisions and research across various oncology indications.
Quick answers
Who was awarded contract 36C24E26N0059?
36C24E26N0059 was awarded to Natera Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on March 3, 2026.
How much is contract 36C24E26N0059 worth?
The government has obligated $73,500 on 36C24E26N0059.
Which agency awarded contract 36C24E26N0059?
Veterans Integrated Service Network 4 (Veterans Health Administration) awarded 36C24E26N0059, with funding from Veterans Integrated Service Network 10 (Veterans Health Administration).
Is contract 36C24E26N0059 an order under another contract?
Yes. 36C24E26N0059 is a delivery order under 36C24E25D0014, an indefinite delivery contract.
Was contract 36C24E26N0059 competed?
The extent of competition for 36C24E26N0059 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award